SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The New Economy and its Winners -- Ignore unavailable to you. Want to Upgrade?


To: Bill Harmond who wrote (41984)4/18/2008 10:17:30 AM
From: Bill Harmond  Respond to of 57684
 
Doubled up lululemon. Added to Amazon.



To: Bill Harmond who wrote (41984)4/18/2008 10:22:01 AM
From: bob zagorin  Respond to of 57684
 
here's the detail on dg.. you have to remember there 20m shares short so there's always 2 sides.. i think wachovia has it right when they say wall street does not understand the strength of the company's platform and pipeline..

Market Report -- Short Stories (ISIS)
April 18, 2008 9:39 AM ET
Isis Pharmaceuticals Inc (ISIS) Stock Quote, Chart, News, Add to Watchlist
Briefing.comAll Briefing.com news

ISIS Pharm downgraded to Mkt Perform at Leerink Swann . Target $25 to $14. Leerink Swann downgrades ISIS to Mkt Perform from Outperform and lowers their tgt to $14 from $25 saying while they appreciate the latest partnership success and more early deals may be struck, firm believes that most positive news is in the stock and potential risks may be overlooked.